Javascript must be enabled to continue!
Anaphylaxis: Long-term management and resources
View through CrossRef
Background: Anaphylaxis is an acute life-threatening event that requires emergent diagnosis and treatment. However, focus on prevention of anaphylaxis is essential in reducing anaphylaxis recurrences and associated mortality. Objective: This literature
review was aimed to be a comprehensive resource for practicing allergists in managing anaphylaxis in the long term. We discussed the role of the allergist in the long-term outpatient management of anaphylaxis through identifying risk factors, allergen avoidance, prevention of recurrences,
and patient education. Methods: A medical literature search that focused on several areas of long-term management of anaphylaxis was conducted. Results: Patients evaluated by an allergist are more likely to have their anaphylaxis trigger identified,
to have their underlying mast cell disorder diagnosed, and to receive desensitization or allergen immunotherapy. Allergists can prevent fatal anaphylaxis by preventing and treating anaphylaxis in patients with ischemic heart disease and by optimally treating patients with comorbid asthma.
Allergists can offer specific prevention strategies for allergenic trigger and cofactor avoidance. Education should be focused on patients with a higher risk for recurrence of anaphylaxis, such as those patients with a history of severe symptoms or anaphylaxis, with a peanut and/or tree nut
trigger, or with a history of asthma, or female gender. Patient counseling involves providing individualized action plans at each visit and discussing proper use, storage, and safety of epinephrine autoinjectors. Multiple doses of epinephrine need to be prescribed to those who are at risk
for severe food-induced, venom immunotherapy‐related, or venom-induced anaphylaxis. Wording on medical identification products should be reviewed by the allergist. Anaphylaxis resources for health-care providers are summarized in the article. Conclusion: Ongoing
education, providing personalized anaphylaxis action plans, reducing risk factors, and avoiding triggers are key to anaphylaxis prevention and long-term management.
Oceanside Publications Inc.
Title: Anaphylaxis: Long-term management and resources
Description:
Background: Anaphylaxis is an acute life-threatening event that requires emergent diagnosis and treatment.
However, focus on prevention of anaphylaxis is essential in reducing anaphylaxis recurrences and associated mortality.
Objective: This literature
review was aimed to be a comprehensive resource for practicing allergists in managing anaphylaxis in the long term.
We discussed the role of the allergist in the long-term outpatient management of anaphylaxis through identifying risk factors, allergen avoidance, prevention of recurrences,
and patient education.
Methods: A medical literature search that focused on several areas of long-term management of anaphylaxis was conducted.
Results: Patients evaluated by an allergist are more likely to have their anaphylaxis trigger identified,
to have their underlying mast cell disorder diagnosed, and to receive desensitization or allergen immunotherapy.
Allergists can prevent fatal anaphylaxis by preventing and treating anaphylaxis in patients with ischemic heart disease and by optimally treating patients with comorbid asthma.
Allergists can offer specific prevention strategies for allergenic trigger and cofactor avoidance.
Education should be focused on patients with a higher risk for recurrence of anaphylaxis, such as those patients with a history of severe symptoms or anaphylaxis, with a peanut and/or tree nut
trigger, or with a history of asthma, or female gender.
Patient counseling involves providing individualized action plans at each visit and discussing proper use, storage, and safety of epinephrine autoinjectors.
Multiple doses of epinephrine need to be prescribed to those who are at risk
for severe food-induced, venom immunotherapy‐related, or venom-induced anaphylaxis.
Wording on medical identification products should be reviewed by the allergist.
Anaphylaxis resources for health-care providers are summarized in the article.
Conclusion: Ongoing
education, providing personalized anaphylaxis action plans, reducing risk factors, and avoiding triggers are key to anaphylaxis prevention and long-term management.
Related Results
Trends in Childhood Anaphylaxis in Singapore: 2015–2022
Trends in Childhood Anaphylaxis in Singapore: 2015–2022
ABSTRACTBackgroundThere has been limited data regarding the incidence of anaphylaxis in Asia. We aim to describe patterns in patient characteristics, triggers and clinical presenta...
EPIDEMIOLOGY OF ANAPHYLAXIS IN COLOMBIA 2010-2015
EPIDEMIOLOGY OF ANAPHYLAXIS IN COLOMBIA 2010-2015
ABSTRACT
Background
The lifetime prevalence of anaphylaxis from all triggers is estimated to range from 0.05 % to 2.6 %. Data o...
Recurrent anaphylaxis in the United States: time of onset and risk factors
Recurrent anaphylaxis in the United States: time of onset and risk factors
BackgroundStudies have not yet examined the trends and risk factors of biphasic and recurrent anaphylaxis in the United States using International Classification of Diseases, tenth...
Pediatric Anaphylaxis: Etiology and Predictive Factors in an Emergency Setting
Pediatric Anaphylaxis: Etiology and Predictive Factors in an Emergency Setting
Anaphylaxis is a serious allergic life-threatening condition that needs immediate treatment to prevent unfavorable outcomes. The present study revealed that the prevalence of anaph...
Anaphylaxis in Children: Experience of an Egyptian Center
Anaphylaxis in Children: Experience of an Egyptian Center
Introduction: Anaphylaxis is a potentially life threatening allergic
reaction that is rapid in onset and multisystemic in nature.
Distribution of anaphylaxis tends to fluctuate bas...
Disseminated Intravascular Coagulation in Anaphylaxis
Disseminated Intravascular Coagulation in Anaphylaxis
AbstractAnaphylaxis is a life-threatening condition that involves severe cutaneous, respiratory, and cardiovascular symptoms. Disseminated intravascular coagulation (DIC) is an acq...
Anaphylaxis in Risky Populations
Anaphylaxis in Risky Populations
Abstract:
Anaphylaxis should be clinically diagnosed with immediate recognition, whereas, despite advances
in the field of allergy, the symptoms of anaphylaxis remain to be under-r...
Markers Involved in Innate Immunity and Neutrophil Activation are Elevated during Acute Human Anaphylaxis: Validation of a Microarray Study
Markers Involved in Innate Immunity and Neutrophil Activation are Elevated during Acute Human Anaphylaxis: Validation of a Microarray Study
<b><i>Background:</i></b> We have previously identified the upregulation of the innate immune response, neutrophil activation, and apoptosis during anaphyla...

